Author: AB Wire

AB Wire stories are filed by American Bazaar staff writers and contributors. If you want to contact one of our reporters, feel free to email editor@americanbazaaronline.com

New study included more than 44,000 diabetes patients in the UK. By Raif Karerat WASHINGTON, DC: Two iterations of diabetes medication may reduce the risk of developing Parkinson’s disease, according to a new study published by researchers at the London School of Hygiene and Tropical Medicine. The study included nearly 44,600 British diabetes patients who took what are known as glitazone drugs — Avandia’s generic name is rosiglitazone, while pioglitazone is the generic name for Actos, according to HealthDay News. Researchers compared data from more than 160,000 diabetes patients in the U.K. and found that patients who took rosiglitazone or…

Read More